Pharmacogenetic studies of thiopurine methyltransferase (TPMT) and thiopurine's toxicity [3];Estudio farmacogenético de la tiopurina S-metiltransferasa (TPMT) y toxicidad de las tiopurinas

Revista Espanola de Enfermedades Digestivas

Volumn 94, Issue 10, 2002, Pages 635-636

  Corominas, H ^a   Diaz C ^a   Vazquez G ^a   Baiget, M ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Azathioprine; Genetic polymorphism; Thiopurine S methyltransferase

Indexed keywords

AZATHIOPRINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOMODULATING AGENT; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; XANTHINE OXIDASE; IMMUNOSUPPRESSIVE AGENT; METHYLTRANSFERASE;

ALLELE; CHROMOSOME 6P; CORRELATION ANALYSIS; DRUG ACTIVITY; ENTERITIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; EXON; GENE DELETION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; MEDICAL INFORMATION; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; GENETICS; METABOLISM;

6-MERCAPTOPURINE; AZATHIOPRINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; METHYLTRANSFERASES; PHARMACOGENETICS;

EID: 1842855471     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Snow JL, Gibson LE. A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients. J Am Acad Dermatol 1995; 32 (1): 114-6.
2. Sandborn WJ, Van OE, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Gastroenterology 1995; 109 (6): 1808-17.
3. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990; 336 (8709): 22-9.
4. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32 (5): 651-62.
5. Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, Marez D, Vinner E, Chevalier ED, et al. Detection of known and new mutations in the thiopurine S- methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat 1998; 12 (3): 177-85.
6. Martinez F, Nos P, Pastor M, Garrigues V, Ponce J. Adverse effects of azathioprine in the treatment of inflammatory bovel disease. Rev Esp Enferm Dig 2001; 93 (12): 774-8.
7. Corominas H, Domenech M, Gonzalez-Juan D, Gonzalez-Suarez B, Diaz C, Pujol J, et al. Aplasia after azathioprine administration: role of the thiopurine methyltransferase genetic polymorphism. Med Clin (Barc) 2000; 11 5 (8): 299-301.
8. Corominas H, Domenech M, González D, Díaz C, Roca M, ía-González MA, et al. Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls. Am J Gastroenterol 2000; 95 (9): 2313-7.